Artivion Inc (AORT)

Stanton Marshall S. 🟡 adjusted position in 18.2K shares (1 derivative) of ARTIVION, INC. (AORT) at $44.02 ($1.2M) Transaction Date: Aug 27, 2025 | Filing ID: 000003

Journey Medical Corporation (DERM)

New Form 8-K - Journey Medical Corp Filed: 2025-08-28 AccNo: 0001104659-25-084879 Size: 582 KB Item 1.01: Entry into a Material Definitive Agreement Item 1.02: Termination of a Material Definitive Agreement Item 9.01: Financial Statements and Exhibits

MITESCO, INC. (MITI)

New Form 8-K - Mitesco, Inc. Filed: 2025-08-28 AccNo: 0001185185-25-001092 Size: 235 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 5.01: Changes in Control of Registrant Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: …

Cingulate Inc. (CING)

New Form 8-K - Cingulate Inc. Filed: 2025-08-28 AccNo: 0001493152-25-012449 Size: 249 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

SAB Biotherapeutics (SABSW)

Reich Samuel J 🟢 acquired 4.8M shares (1 derivative) of SAB Biotherapeutics, Inc. (SABS) at $2.17 ($10.4M) Transaction Date: Aug 26, 2025 | Filing ID: 112077